Global Prostaglandin E2 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI02254862

Publication Date:

February 27, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Prostaglandin E2 market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Prostaglandin E2 (PGE2), also known as dinoprostone, is a naturally occurring prostaglandin with oxytocic properties that is used as a medication.
Dinoprostone is used in labor induction, bleeding after delivery, termination of pregnancy, and in newborn babies to keep the ductus arteriosus open. In babies it is used in those with congenital heart defects until surgery can be carried out. It is also used to manage gestational trophoblastic disease. It may be used within the vagina or by injection into a vein.
The 鈥淧rostaglandin E2 Industry Forecast鈥� looks at past sales and reviews total world Prostaglandin E2 sales in 2024, providing a comprehensive analysis by region and market sector of projected Prostaglandin E2 sales for 2025 through 2031. With Prostaglandin E2 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prostaglandin E2 industry.
This Insight Report provides a comprehensive analysis of the global Prostaglandin E2 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Prostaglandin E2 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Prostaglandin E2 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prostaglandin E2 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prostaglandin E2.
This report presents a comprehensive overview, market shares, and growth opportunities of Prostaglandin E2 market by product type, application, key players and key regions and countries.
Segmentation by Type:
Low Purity(Below 97%)
Purity(Above 97% and Below 99%)
High Purity(Above 99%)
Others
Segmentation by Application:
Cancer Treatment
Neurological Treatment
Endocrinological Treatment
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
R&D Systems
Abcam
Stemgent
Cayman Chemical
Santa Cruz Biotechnology
STEMCELL Technologies
AbMole Bioscience
Bio-Techne

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Prostaglandin E2 麻豆原创 Size (2020-2031)
2.1.2 Prostaglandin E2 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Prostaglandin E2 by Country/Region (2020, 2024 & 2031)
2.2 Prostaglandin E2 Segment by Type
2.2.1 Low Purity(Below 97%)
2.2.2 Purity(Above 97% and Below 99%)
2.2.3 High Purity(Above 99%)
2.2.4 Others
2.3 Prostaglandin E2 麻豆原创 Size by Type
2.3.1 Prostaglandin E2 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Prostaglandin E2 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Prostaglandin E2 Segment by Application
2.4.1 Cancer Treatment
2.4.2 Neurological Treatment
2.4.3 Endocrinological Treatment
2.4.4 Others
2.5 Prostaglandin E2 麻豆原创 Size by Application
2.5.1 Prostaglandin E2 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Prostaglandin E2 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Prostaglandin E2 麻豆原创 Size by Player
3.1 Prostaglandin E2 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Prostaglandin E2 Revenue by Player (2020-2025)
3.1.2 Global Prostaglandin E2 Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Prostaglandin E2 Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Prostaglandin E2 by Region
4.1 Prostaglandin E2 麻豆原创 Size by Region (2020-2025)
4.2 Global Prostaglandin E2 Annual Revenue by Country/Region (2020-2025)
4.3 Americas Prostaglandin E2 麻豆原创 Size Growth (2020-2025)
4.4 APAC Prostaglandin E2 麻豆原创 Size Growth (2020-2025)
4.5 Europe Prostaglandin E2 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Prostaglandin E2 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Prostaglandin E2 麻豆原创 Size by Country (2020-2025)
5.2 Americas Prostaglandin E2 麻豆原创 Size by Type (2020-2025)
5.3 Americas Prostaglandin E2 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prostaglandin E2 麻豆原创 Size by Region (2020-2025)
6.2 APAC Prostaglandin E2 麻豆原创 Size by Type (2020-2025)
6.3 APAC Prostaglandin E2 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Prostaglandin E2 麻豆原创 Size by Country (2020-2025)
7.2 Europe Prostaglandin E2 麻豆原创 Size by Type (2020-2025)
7.3 Europe Prostaglandin E2 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Prostaglandin E2 by Region (2020-2025)
8.2 Middle East & Africa Prostaglandin E2 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Prostaglandin E2 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Prostaglandin E2 麻豆原创 Forecast
10.1 Global Prostaglandin E2 Forecast by Region (2026-2031)
10.1.1 Global Prostaglandin E2 Forecast by Region (2026-2031)
10.1.2 Americas Prostaglandin E2 Forecast
10.1.3 APAC Prostaglandin E2 Forecast
10.1.4 Europe Prostaglandin E2 Forecast
10.1.5 Middle East & Africa Prostaglandin E2 Forecast
10.2 Americas Prostaglandin E2 Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Prostaglandin E2 Forecast
10.2.2 Canada 麻豆原创 Prostaglandin E2 Forecast
10.2.3 Mexico 麻豆原创 Prostaglandin E2 Forecast
10.2.4 Brazil 麻豆原创 Prostaglandin E2 Forecast
10.3 APAC Prostaglandin E2 Forecast by Region (2026-2031)
10.3.1 China Prostaglandin E2 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Prostaglandin E2 Forecast
10.3.3 Korea 麻豆原创 Prostaglandin E2 Forecast
10.3.4 Southeast Asia 麻豆原创 Prostaglandin E2 Forecast
10.3.5 India 麻豆原创 Prostaglandin E2 Forecast
10.3.6 Australia 麻豆原创 Prostaglandin E2 Forecast
10.4 Europe Prostaglandin E2 Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Prostaglandin E2 Forecast
10.4.2 France 麻豆原创 Prostaglandin E2 Forecast
10.4.3 UK 麻豆原创 Prostaglandin E2 Forecast
10.4.4 Italy 麻豆原创 Prostaglandin E2 Forecast
10.4.5 Russia 麻豆原创 Prostaglandin E2 Forecast
10.5 Middle East & Africa Prostaglandin E2 Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Prostaglandin E2 Forecast
10.5.2 South Africa 麻豆原创 Prostaglandin E2 Forecast
10.5.3 Israel 麻豆原创 Prostaglandin E2 Forecast
10.5.4 Turkey 麻豆原创 Prostaglandin E2 Forecast
10.6 Global Prostaglandin E2 Forecast by Type (2026-2031)
10.7 Global Prostaglandin E2 Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Prostaglandin E2 Forecast
11 Key Players Analysis
11.1 R&D Systems
11.1.1 R&D Systems Company Information
11.1.2 R&D Systems Prostaglandin E2 Product Offered
11.1.3 R&D Systems Prostaglandin E2 Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 R&D Systems Main Business Overview
11.1.5 R&D Systems Latest Developments
11.2 Abcam
11.2.1 Abcam Company Information
11.2.2 Abcam Prostaglandin E2 Product Offered
11.2.3 Abcam Prostaglandin E2 Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Abcam Main Business Overview
11.2.5 Abcam Latest Developments
11.3 Stemgent
11.3.1 Stemgent Company Information
11.3.2 Stemgent Prostaglandin E2 Product Offered
11.3.3 Stemgent Prostaglandin E2 Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Stemgent Main Business Overview
11.3.5 Stemgent Latest Developments
11.4 Cayman Chemical
11.4.1 Cayman Chemical Company Information
11.4.2 Cayman Chemical Prostaglandin E2 Product Offered
11.4.3 Cayman Chemical Prostaglandin E2 Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Cayman Chemical Main Business Overview
11.4.5 Cayman Chemical Latest Developments
11.5 Santa Cruz Biotechnology
11.5.1 Santa Cruz Biotechnology Company Information
11.5.2 Santa Cruz Biotechnology Prostaglandin E2 Product Offered
11.5.3 Santa Cruz Biotechnology Prostaglandin E2 Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Santa Cruz Biotechnology Main Business Overview
11.5.5 Santa Cruz Biotechnology Latest Developments
11.6 STEMCELL Technologies
11.6.1 STEMCELL Technologies Company Information
11.6.2 STEMCELL Technologies Prostaglandin E2 Product Offered
11.6.3 STEMCELL Technologies Prostaglandin E2 Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 STEMCELL Technologies Main Business Overview
11.6.5 STEMCELL Technologies Latest Developments
11.7 AbMole Bioscience
11.7.1 AbMole Bioscience Company Information
11.7.2 AbMole Bioscience Prostaglandin E2 Product Offered
11.7.3 AbMole Bioscience Prostaglandin E2 Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 AbMole Bioscience Main Business Overview
11.7.5 AbMole Bioscience Latest Developments
11.8 Bio-Techne
11.8.1 Bio-Techne Company Information
11.8.2 Bio-Techne Prostaglandin E2 Product Offered
11.8.3 Bio-Techne Prostaglandin E2 Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Bio-Techne Main Business Overview
11.8.5 Bio-Techne Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.